{"id":"W1972272153","doi":"10.1016/j.lungcan.2014.04.014","title":"Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)","year":2014,"lang":"en","type":"article","venue":"Lung Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Medicine; Erlotinib; Internal medicine; Oncology; Bevacizumab; Clinical endpoint; Lung cancer; Chemotherapy; Clinical trial; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001748023,0.0003057214,0.0002533556,0.00006083064,0.0001493824,0.00002999959,0.0001743379,0.0001922116,0.00003122282],"category_scores_gemma":[0.00007653728,0.000282594,0.00007993827,0.0001800973,0.00005081882,0.00001465888,0.00005965269,0.0001240955,0.000001606633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003026527,"about_ca_system_score_gemma":0.0001394365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002957239,"about_ca_topic_score_gemma":0.00007333236,"domain_scores_codex":[0.9981849,0.00008230878,0.0003524793,0.0006612173,0.0002748242,0.0004442316],"domain_scores_gemma":[0.9990013,0.0000276722,0.0003259,0.0004055195,0.000115,0.0001245543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009116184,0.00009995319,0.3612967,0.0001292076,0.00002900562,0.000001181904,0.00007277914,0.002455159,0.623096,5.404704e-7,0.0005228167,0.01138499],"study_design_scores_gemma":[0.01707282,0.0005403041,0.1654027,0.0008757177,0.00006123201,0.000002219959,0.00002095471,0.01179399,0.8007483,0.000005050705,0.002498961,0.0009777049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960027,0.0008634846,0.001534193,0.00008775907,0.0001474905,0.001169877,0.0000351561,0.00003716724,0.0001221781],"genre_scores_gemma":[0.9958408,0.00001176396,0.002728157,0.0002620184,0.0001112998,0.0002176853,0.0006526998,0.00008985293,0.00008576375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.195894,"threshold_uncertainty_score":0.9999626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003084220057585393,"score_gpt":0.2517207422601649,"score_spread":0.2486365222025796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}